In conclusion, our study suggests that although sPD and LRRK2-PD share defining aspects of neuropathology and clinical characteristics, the molecular pathways underlying the etiology and pathogenesis of the two conditions have important distinct features. The gene discussed is LRRK2; the disease is Parkinson disease.